Comment on ‘Real-world outcomes of stapokibart-based combination therapy for bullous pemphigoid: a single-centre retrospective cohort’: towards controlled comparisons, neurological profiling and long-term follow-up

Clinical and Experimental Dermatology 2026

View at publisher
Authors: Yiying Xiao, Weikai Dong, Yuhong Zhu
DOI: 10.1093/ced/llag303
Cited by: 1
References: 5

Abstract

Our comment highlights several issues in a recent single-centre retrospective cohort study of stapokibart for bullous pemphigoid. We advocate for multicentre controlled trials with extended observation to establish robust evidence for this emerging therapy.

Fields of Study & Subjects

Autoimmune Bullous Skin Diseases Sympathectomy and Hyperhidrosis Treatments Dermatology and Skin Diseases

Publication details

Journal / source
Clinical and Experimental Dermatology
Publisher
Oxford University Press (OUP)
Publication date
15 July 2026
Language
EN